REZI CFO Sells 2,334 Shares at $31.60 — Form 4 Disclosure
Michael Carlet, Chief Financial Officer of Resideo Technologies, Inc. (REZI), reported a sale of 2,334 shares of the company's common stock on 08/15/2025 at a price of $31.60 per share.
Rhea-AI Filing Summary
Michael Carlet, Chief Financial Officer of Resideo Technologies, Inc. (REZI), reported a sale of 2,334 shares of the company's common stock on 08/15/2025 at a price of $31.60 per share. Following this transaction he beneficially owned 158,527 shares. The Form 4 was signed by an attorney-in-fact on 08/19/2025.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider sale of 2,334 shares, leaving 158,527 shares owned; routine disclosure with limited investor impact.
The reported sale is a small, non-derivative disposition by the CFO and does not include any accompanying commentary about intent or plans. The transaction size relative to total reported holdings appears modest and there are no derivative or exercise events disclosed. This Form 4 documents compliance with Section 16 reporting requirements rather than signaling a material corporate change.
TL;DR: Properly executed Form 4 filing for an officer sale; disclosure appears complete and timely.
The form identifies the reporting person, relationship to the issuer as CFO, the transaction date, transaction code and price, and the post-transaction beneficial ownership. The signature by an attorney-in-fact is provided. There are no indications of rule 10b5-1 plan filings or additional agreements in this filing.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common Stock | 2,334 | $31.60 | $74K |
FAQ
What transaction did REZI CFO Michael Carlet report on Form 4?
When was the Form 4 for Michael Carlet signed and by whom?
Was the reported transaction a derivative transaction or a non-derivative transaction?
Does the Form 4 mention a 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.